Milwaukee Health Department answers questions from Common Council members about J&J vaccine

-
3:03
Bucks introduce Lillard at Media Day
-
1:45
Culver’s brings back popular ’Curderburger’ for month of...
-
1:18
Man sentenced to 25 years in DUI crash that killed nurse
-
1:51
Student loan repayment begins for millions
-
2:01
Jury trial moving forward for former Milwaukee police officer...
-
1:21
Groundbreaking held for Milwaukee County’s new health and human...
-
1:58
Fans encouraged to get hyped ahead of Brewers first playoff game
-
4:06
Closer look at Sheboygan’s Sunday Dough
-
3:32
Wisconsin BBB warns against purchasing flood-damaged used cars
-
2:26
Recapping September heat and a look at first week of October...
-
2:41
Some squeaky clean fun for this Saturday’s ’Curd Fest’...
-
2:20
’Happy Hour for the Homeless’ kicks off in Milwaukee, 55+...
MILWAUKEE (CBS 58) —Everyone 16 and older can now get the COVID-19 vaccine across the country. That’s been the case in Wisconsin for a few weeks.
Milwaukee health officials are watching vaccination rates. At the same time, Common Council members have questions after the pausing of the Johnson & Johnson vaccine.
Last week, the CDC & FDA recommended a pause on the J&J vaccine over six reported cases of a blood clot. The cases were among more than 6.8 million doses of the Johnson & Johnson vaccine that had been given out around the country.
Milwaukee Health Commissioner Kirsten Johnson says about 1,540 people received the Johnson & Johnson vaccine from the Milwaukee Health Department.
She was asked if those who received the vaccine have been contacted.
“It’s challenging some, where they're shelters, some of the organizations have contacted everyone and made it public as possible,” said Johnson.
Dr. Ben Weston, with the Milwaukee County Office of Emergency Management, says they also reached out to people who had received it.
“Just notified them that there were these findings, the risk is very low, I think they still made a very good decision in getting the vaccine. If Johnson & Johnson is back and available in a week, I still think it's an outstanding vaccine.”